Holen Sie sich die Stockscreener-App
13.13
7.01%
-0.99
Handel nachbörslich:
13.13
Schlusskurs vom Vortag:
$14.12
Offen:
$13.91
24-Stunden-Volumen:
1.48M
Relative Volume:
0.64
Marktkapitalisierung:
$895.35M
Einnahmen:
$2.66B
Nettoeinkommen (Verlust:
$-1.21B
KGV:
-0.7368
EPS:
-17.82
Netto-Cashflow:
$-159.40M
1W Leistung:
-2.74%
1M Leistung:
+27.23%
6M Leistung:
-55.32%
1J Leistung:
-53.16%
1-Tages-Spanne:
$13.01
$14.36
1-Wochen-Bereich:
$12.87
$14.99
52-Wochen-Spanne:
$9.92
$35.58
Quidelortho Corp Stock (QDEL) Company Profile
Firmenname
Quidelortho Corp
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
13.13 | 993.54M | 2.66B | -1.21B | -159.40M | -17.82 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corp Aktie (QDEL) Neueste Nachrichten
QuidelOrtho and Allo Hope Foundation partner to advance prenatal care for maternal alloimmunization - Select Science
Is the options market predicting a spike in QuidelOrtho stock? - MSN
QuidelOrtho (QDEL) up 24.1% since last earnings report: Can it continue? - MSN
Is the Options Market Predicting a Spike in QuidelOrtho Stock? - TradingView
QuidelOrtho (QDEL) director receives 1,183 shares from restricted stock unit release - Stock Titan
QuidelOrtho (QDEL) director settles 973 RSUs into common stock award - Stock Titan
QuidelOrtho (NASDAQ: QDEL) director gains 2,156 shares via RSU release - Stock Titan
QuidelOrtho Corp (QDEL) director gains 1,252 shares from RSU release - Stock Titan
QuidelOrtho CorporationCommon Stock (NQ: QDEL - FinancialContent
A Look At QuidelOrtho (QDEL) Valuation After Recent Share Price Rebound And Longer Term Weakness - Yahoo Finance
Assessing QuidelOrtho (QDEL) Valuation After A Sharp One Month Share Price Rebound - simplywall.st
QuidelOrtho (QDEL) Up 24.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk - TradingView
QuidelOrtho Corporation (QDEL) Presents at 46th Annual William Blair Growth Stock ConferenceSlideshow - Seeking Alpha
QuidelOrtho Corp stock (US7476011036): partnership news and conference appearance in focus - AD HOC NEWS
QuidelOrtho (QDEL) director adds 6,829 shares via RSU vesting - Stock Titan
Director at QuidelOrtho (QDEL) gains 6,829 shares through RSU vesting - Stock Titan
QuidelOrtho (QDEL) director RSUs vest into 6,829 shares, holding 19,469 directly - Stock Titan
QuidelOrtho (QDEL) director adds 6,829 shares through RSU vesting - Stock Titan
QuidelOrtho (QDEL) director gains 6,829 shares as RSUs vest - Stock Titan
Director R. Scott Huennekens gains 6,829 QuidelOrtho (QDEL) shares via RSU vesting - Stock Titan
QuidelOrtho Corp (QDEL) director awarded 6,829 shares in equity grant - Stock Titan
QuidelOrtho (QDEL) director Ann D. Rhoads receives 6,829 shares as RSUs vest - Stock Titan
Director at QuidelOrtho (QDEL) gains 6,829 shares via RSU vesting - Stock Titan
QuidelOrtho (QDEL) director awarded 6,829 shares via RSU vesting - Stock Titan
QuidelOrtho and Allo Hope Foundation Join Forces to Advance Educ - GuruFocus
QuidelOrtho Partners with Allo Hope Foundation for Early Pregnan - GuruFocus
QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies - Barchart
McIntyre Partnerships’ Analysis on QuidelOrtho Corporation (QDEL) - Insider Monkey
QuidelOrtho Corp stock (US7476011036): shares volatile after Q1 2026 loss and outlook reset - AD HOC NEWS
QuidelOrtho (QDEL) reports Q1 loss, tops revenue estimates - MSN
QuidelOrtho Corp stock (US7476011036): director share purchase and CFO transition in focus - AD HOC NEWS
A Look at QuidelOrtho Corp (QDEL) After 6.0% Gain -- GF Value $3 - GuruFocus
Director at QuidelOrtho (QDEL) receives 1,407 shares from RSU release - Stock Titan
QuidelOrtho Q1 2026 Earnings: EPS Misses Estimates Sharply, Stock Declines 4.28%Fiscal Year Earnings - thelegaladvocate.com
QuidelOrtho Corp (QDEL) Stock Down 4.2% -- Now Undervalued? GF S - GuruFocus
How Quidelortho Corp Com (QDEL) Affects Rotational Strategy Timing - Stock Traders Daily
When Blood Compatibility Becomes a Pregnancy Risk – Company Announcement - Financial Times
QuidelOrtho stock (US7476011036): Shares rise after latest market move - AD HOC NEWS
When blood compatibility becomes a threat in pregnancy, and how tests help - Stock Titan
QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences - Yahoo Finance
QuidelOrtho (QDEL) price target decreased by 34.46% to 19.25 - MSN
QuidelOrtho stock (US7476011036): Shares fall after recent after-hours pressure - AD HOC NEWS
QuidelOrtho Corp stock (US7476011036): analysts divided as short interest climbs and sentiment weake - AD HOC NEWS
5 Insightful Analyst Questions From QuidelOrtho’s Q1 Earnings Call - Yahoo Finance
QuidelOrtho Corp (QDEL) Shares Surge 3.0% -- What GF Score of 48 Tells Investors - GuruFocus
Finanzdaten der Quidelortho Corp-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Quidelortho Corp-Aktie (QDEL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Busky Joseph M. | Chief Financial Officer |
Feb 13 '26 |
Buy |
23.66 |
3,370 |
79,742 |
10,290 |
| Blaser Brian J. | President and CEO |
Feb 13 '26 |
Buy |
23.59 |
10,540 |
248,661 |
40,073 |
| RHOADS ANN D | Director |
Dec 10 '25 |
Buy |
28.27 |
750 |
21,206 |
15,021 |
| Wilkins Joseph D Jr. | Director |
Nov 26 '25 |
Buy |
27.95 |
370 |
10,343 |
11,876 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Option Exercise |
15.74 |
7,021 |
110,511 |
41,087 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Sale |
27.81 |
4,026 |
111,965 |
37,061 |
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):